
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT
- About


Milestone Scientific (MLSS)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/14/2025: MLSS (1-star) is currently NOT-A-BUY. Pass it for now.
1 Year Target Price $2.12
1 Year Target Price $2.12
1 | Strong Buy |
1 | Buy |
0 | Hold |
0 | Sell |
0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -48.8% | Avg. Invested days 27 | Today’s Advisory PASS |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 51.01M USD | Price to earnings Ratio - | 1Y Target Price 2.12 |
Price to earnings Ratio - | 1Y Target Price 2.12 | ||
Volume (30-day avg) 2 | Beta 0.8 | 52 Weeks Range 0.38 - 1.39 | Updated Date 08/15/2025 |
52 Weeks Range 0.38 - 1.39 | Updated Date 08/15/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.06 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2025-08-19 | When - | Estimate -0.01 | Actual -0.02 |
Profitability
Profit Margin -61.16% | Operating Margin (TTM) -89.49% |
Management Effectiveness
Return on Assets (TTM) -44.58% | Return on Equity (TTM) -88.36% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 43526373 | Price to Sales(TTM) 5.92 |
Enterprise Value 43526373 | Price to Sales(TTM) 5.92 | ||
Enterprise Value to Revenue 5.05 | Enterprise Value to EBITDA -6.86 | Shares Outstanding 78477296 | Shares Floating 62026904 |
Shares Outstanding 78477296 | Shares Floating 62026904 | ||
Percent Insiders 21.45 | Percent Institutions 5.95 |
Upturn AI SWOT
Milestone Scientific

Company Overview
History and Background
Milestone Scientific Inc. was founded in 1989. It initially focused on computer-controlled drug delivery technology. It has evolved into a medical device company specializing in computerized anesthesia and drug delivery systems.
Core Business Areas
- Dental: Focuses on the CompuDent system, a computer-controlled local anesthesia delivery system (CALADS) for dental applications, aiming to reduce patient anxiety and pain during injections.
- Medical: Develops and markets the CompuFlo Epidural and intrathecal anesthesia delivery system, designed for precise drug delivery in pain management and other medical procedures.
Leadership and Structure
Leonard Osser serves as the Chief Executive Officer. The company has a board of directors overseeing its strategic direction and operations. The structure includes sales, marketing, R&D, and manufacturing departments.
Top Products and Market Share
Key Offerings
- CompuDent: A computer-controlled local anesthesia delivery system (CALADS) for dental use. Its market share is estimated to be less than 5% of the total local anesthesia delivery market, facing competition from traditional syringes and other CALADS systems. Competitors include Septodont, Dentsply Sirona, and other anesthesia delivery system manufacturers. Revenue information is not publicly disclosable.
- CompuFlo Epidural: A system designed for precise drug delivery during epidural anesthesia procedures. Its market share in this segment is also relatively small, given the established techniques and competitors in the pain management device market. Competitors include Becton Dickinson, Smiths Medical, and other large medical device companies. Revenue information is not publicly disclosable.
Market Dynamics
Industry Overview
The medical device industry is characterized by technological innovation, regulatory scrutiny, and competitive pressure. The market for anesthesia delivery systems is driven by the need for improved patient comfort and precise drug administration.
Positioning
Milestone Scientific is positioned as a provider of innovative computer-controlled drug delivery systems, focusing on improving precision and patient experience. It differentiates itself through its patented technology and targeted marketing towards specific applications like dental and epidural anesthesia.
Total Addressable Market (TAM)
The global market for anesthesia delivery systems is estimated to be in the billions of dollars. Milestone Scientific is positioned to capture a portion of this TAM by focusing on niche applications and technological advancements.
Upturn SWOT Analysis
Strengths
- Patented technology for computer-controlled drug delivery
- Focus on improving patient comfort and precision
- Targeted marketing efforts
- Specialized in dental and medical fields
Weaknesses
- Limited market share compared to larger competitors
- Reliance on specific product lines
- Potential dependence on key personnel
- Small market capitalization
Opportunities
- Expansion into new applications and markets
- Partnerships with dental and medical professionals
- Increased adoption of CALADS technology
- Acquisitions for scale
Threats
- Competition from established medical device companies
- Regulatory changes and approvals
- Economic downturns affecting healthcare spending
- Technological obsolescence
Competitors and Market Share
Key Competitors
- Dentsply Sirona (XRAY)
- Becton Dickinson (BDX)
- Septodont (Private)
Competitive Landscape
Milestone Scientific faces competition from larger, more established medical device companies. Its advantages include its patented technology and focus on niche applications. Disadvantages include its smaller size and limited resources.
Growth Trajectory and Initiatives
Historical Growth: Historical growth has been driven by product sales and market expansion efforts.
Future Projections: Future growth is projected to be driven by increased adoption of its products in dental and medical markets, as well as potential new product launches.
Recent Initiatives: Recent initiatives include expanding the sales team, marketing campaigns, and developing new product features.
Summary
Milestone Scientific is a small company in the medical device sector with innovative technology but limited market share. It faces competition from larger players but has growth potential through new applications and partnerships. Financial performance is key to monitor for long-term sustainability and expansion.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Milestone Scientific's investor relations website
- SEC filings (e.g., 10-K reports)
- Market research reports
- Industry news articles
Disclaimers:
This analysis is based on publicly available information and estimates. It is not financial advice, and investors should conduct their own due diligence before making investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Milestone Scientific
Exchange NYSE MKT | Headquaters Roseland, NJ, United States | ||
IPO Launch date 1995-11-03 | CEO - | ||
Sector Healthcare | Industry Medical Instruments & Supplies | Full time employees 17 | |
Full time employees 17 |
Milestone Scientific Inc., a biomedical technology company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical and dental use in the United States, China, and internationally. It operates through Dental and Medical segments. The company provides the Wand, a single use disposable handpiece device for dental procedures that require local anesthetic under the CompuDent and STA Single Tooth Anesthesia System names. It also offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances; and disposable injection handpiece for the tactile control during the injection. In addition, the company provides CompuFlo Epidural, a computer-controlled anesthesia system for use in various medical applications. Further, it offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Roseland, New Jersey.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.